| Net income (loss) | 7.07M |
| Depreciation | 19.26M |
| Asset impairments | 0 |
| Deferred income taxes | |
| Compensation expense - restricted stock | 2.45M |
| Excess tax benefit from share-based payment arrangements | |
| Contracts receivable | |
| Contract retainage | |
| Costs and estimated earnings in excess of billings on uncompleted contracts | |
| Prepaid expenses and other assets | 915K |
| Other receivables | |
| Inventory | 135K |
| Accounts payable | -13.65M |
| Billings in excess of costs and estimated earnings on uncompleted contracts | -20K |
| Accrued employee costs | 1.4M |
| Accrued expenses | 2.73M |
| Current income taxes | 413K |
| Net cash (used in) provided by operating activities | |
| Capital expenditures, net | -5.42M |
| Net cash used in investing activities | |
| Proceeds from exercise of stock options | |
| Excess tax benefit from share-based payment arrangements | |
| Payments of dividends on common stock | -440K |
| Net cash used in financing activities | |
| Net change in cash and cash equivalents | 20.81M |
| Cash and cash equivalents at beginning of period | 34.83M |
| Cash and cash equivalents at end of period | 55.64M |